FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Capreomycin Injection, USP
Status: Currently in Shortage
»Date first posted: 05/21/2019
»Therapeutic Categories: Anti-Infective

Akorn Pharmaceuticals (New 05/21/2019)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Capastat Sulfate (Capreomycin for Injection USP) Eq to 1 g Capreomycin activity, 10mL (NDC 17478-080-50) Product is currently unavailable. Estimated shortage duration is until 4Q2019. Estimated recovery 4Q2019 Delay in shipping of the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English